Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook



 

NgAgo is a no-go

07 August 2017

By Rachel Siden

Appeared in BioNews 912

The original paper promoting a new genome editing technology known as Natronobacterium gregoryi Argonaute (NgAgo) has been retracted.

The retraction follows repeated failures to repeat the results described. Published in Nature Biotechnology in May 2016, the paper created a media sensation in China when it was suggested that NgAgo could supersede the CRISPR/Cas9 genome editing system.

However, the paper quickly drew widespread criticism as scientists began reporting an inability to reproduce the results.

'Despite the efforts of many laboratories, an independent replication of [our] results has not been reported,' the scientists, led by Dr Chunyu Han of Hebei University of Science and Technology, stated in their retraction notice. 'We are therefore retracting our initial report at this time to maintain the integrity of the scientific record.'

NgAgo appeared to show advantages over the CRISPR/Cas9 system - greater guide stability, reduced off-target editing, and the use of reagents that are easier to synthesise and handle.

But scientists who could not reproduce the results using the described protocols soon began citing their concerns over social media, in blogs, and in published papers. In November 2016, Nature Biotechnology published an expression of concern alongside the paper, presenting a collection of data that challenged the original findings.

Dr Han's team and other independent groups responded by coming to the journal with new data supporting the reproducibility of NgAgo genome editing, but could not sufficiently refute the growing amount of research that continued to challenge the original findings.

'Some of us have even sent visiting researchers to [Dr] Han's laboratory but they were not allowed to perform genome editing experiments involving mammalian cells when they were there,' a team of Chinese and US scientists led by Dr Shawn Burgess of the National Human Genome Research Institute reported in November 2016 to the journal Protein & Cell. 'Consequently, none of them returned with any information confirming Han's data.'

An editorial by Nature Biotechnology concluded: 'We are now convinced that the decision of Han and colleagues to retract the paper is the best course of action to support the integrity of the published record.... When it comes to biology, answers are often not definitive. And when it comes to replication studies, the one thing we know is that it takes time. In the case of NgAgo, the time has come and the data have spoken.'

Though the NgAgo controversy has led to the original paper's retraction, Dr Han and his team have not given up on NgAgo, stating in the retraction notice: 'We nevertheless continue to investigate the reasons for this lack of reproducibility with the aim of providing optimised protocol.'

SOURCES & REFERENCES
Retraction Watch | 02 August 2017
 
Nature News | 03 August 2017
 
Nature Biotechnology | 02 August 2017
 
GenomeWeb | 03 August 2017
 
The Scientist | 21 November 2016
 
Nature Biotechnology | 02 August 2017
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

15 February 2016 - by Kirsty Oswald 
The world-renowned Karolinska Institute is at the centre of a scandal surrounding the conduct of stem-cell surgeon Paulo Macchiarini...
07 July 2014 - by Antony Blackburn-Starza 
Nature has retracted two papers published in January on the creation of so-called 'STAP' cells, after all co-authors agreed to the retractions....
25 July 2011 - by Dr Lux Fatimathas 
The journal Science has retracted a controversial paper on the genetics of extreme longevity by scientists at Boston University. The paper, released online last year, was retracted before publication in print following a formal ‘expression of concern’ regarding fundamental technical flaws....
27 September 2010 - by Dr Jay Stone 
Questions continue to be asked after Dr Savio Woo, a gene therapist at the Mount Sinai School of Medicine in New York, was forced to retract two more of his papers last week. Dr Woo has retracted six papers this year after two of his post-docs, Li Chen and Zhiyu Li, were accused of scientific misconduct....

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation